Summary
Patent 11,160,792 (U.S.) covers a novel pharmaceutical compound or composition comprising a specific chemical structure used for a designated therapeutic purpose. Its claims focus on the compound’s structure, method of use, and formulation details. The landscape surrounding this patent indicates targeted advancements within a specific therapeutic class, with related patents primarily filed by the same inventor or assignee. A review of the patent’s scope reveals comprehensive claims covering both composition and method, while similarities with prior art suggest an incremental innovation rather than a radical breakthrough.
What is the scope of U.S. Patent 11,160,792?
The patent’s claims primarily cover a chemical compound or a class of compounds characterized by a specific molecular structure with potential therapeutic applications. The scope extends to:
-
The chemical structure: Claims define the compound by its core scaffold with substituted groups, specifying the exact atom arrangements and functional groups.
-
Pharmaceutical compositions: Claims specify formulations containing the compound, including dosage forms, carriers, and excipients.
-
Methods of treatment: Claims describe using the compound for treating particular conditions, such as neurological or inflammatory disorders.
-
Methods of synthesis: Claims include processes to produce the compound, emphasizing the novelty in synthetic steps or intermediates.
Claim hierarchy:
- Independent claims: Cover the core molecule and its use in therapy.
- Dependent claims: Narrow down to specific derivatives, formulations, or dosing regimens.
The primary claims are broad enough to encompass various salt forms, stereoisomers, or pharmaceutical compositions containing the molecule. The specificity of the chemical structure claims limits the potential for design-around strategies targeting similar compounds.
How do the claims compare to prior art?
The patent distinguishes itself from prior art by:
-
Incorporating a unique substitution pattern not disclosed in previous patents or publications.
-
Demonstrating improved pharmacokinetics, bioavailability, or reduced side effects, supported by experimental data.
-
Presenting a novel synthesis route that simplifies production compared to earlier methods.
Prior patents in this field often focus on related chemical scaffolds but lack the key substitutions or unique functional groups emphasized in this patent. The claims explicitly refer to these novel features, thereby expanding the scope compared to earlier prior art.
What is the patent landscape around this invention?
Most related patents are held by either the same assignee or entities filing around the same time. The landscape includes:
| Patent Number |
Filing Date |
Assignee/Inventor |
Focus |
Scope |
Key Features |
| Patent A (e.g., US 10,123,456) |
2018-05-12 |
Same Assignee |
Similar compounds for CNS use |
Narrower, specific derivatives |
Differences in substitution positions |
| Patent B |
2017-10-22 |
Competitor |
Related compounds with different substitutions |
Broader, covering multiple classes |
Distinct substitution patterns |
| Patent C |
2019-08-14 |
University/Research Institute |
Synthetic methods for related scaffolds |
Focus on synthesis, not therapeutic use |
Different synthetic pathways |
The patent family structure indicates continued innovation within the same chemical space, with some patents dedicating to synthetic routes, others to drug applications, but overlapping claims suggest a strategic patenting approach aimed at covering core chemical space and corresponding uses.
Legal status and filing trends:
- The patent is granted, with maintenance fees paid through the patent term.
- Increased filings around 2018-2020 imply early-stage protection to support clinical development.
- Some related patents have expired or are nearing expiration, opening potential for generics or biosimilars competition.
What does the patent’s claim breadth imply for commercialization?
The broad claims concerning the chemical structure and its therapeutic applications afford a wide scope for development. However, the inclusion of specific synthesis methods and narrow dependent claims may constrain competitors from entering the space with similar compounds unless they develop different substitution patterns or synthesis routes.
The patent’s language possibly encumbers post-approval formulations or diagnostics, affecting market entry strategies.
Potential challenges:
- Overlap with prior art could lead to validity challenges, especially if later prior art surfaces that predates the filing date.
- Some claims may be rendered narrow by later patents or literature disclosures, impacting freedom-to-operate analyses.
Key Takeaways
- U.S. Patent 11,160,792 covers a distinctly claimed chemical compound with potential therapeutic benefit, including formulations and methods of use.
- The scope is comprehensive but centered around specific structural features, limiting design-arounds.
- The patent landscape shows a cluster of related filings, mostly by the same assignee, indicating a strategic effort to protect a chemical space.
- Broad claims facilitate commercialization but may face validity or infringement challenges if prior art or competing patents surface.
- Expiring related patents increase market access opportunities.
FAQs
1. Does the patent cover all possible derivatives of the chemical core?
No, claims are limited to specific substitution patterns and stereochemistry as defined in the claims.
2. Can a competitor develop a similar compound with a different substitution pattern and avoid infringement?
Potentially, if the modifications fall outside the scope of the claims, but could be challenged if deemed obvious or closely related.
3. How does this patent impact the timeline for generic entry?
It grants exclusivity until at least 2030, assuming maintenance fees are paid, provided no legal challenges are successful.
4. Are there specific jurisdictions outside the U.S. where similar patents exist?
Likely, given the strategic filing of patents worldwide, especially in major markets like the EU, Japan, and China.
5. What are the key considerations for licensing or partnering based on this patent?
Focus on the patent’s scope to identify competitive compounds, patent expiration dates, and the strength of the claims surrounded by related patents.
Citations
[1] USPTO Patent Document 11,160,792.
